Michael Philip Dougherty serves as Executive at bioAffinity Technologies, Inc., where they oversee executive responsibilities. Since joining the company, Michael Philip Dougherty has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 31, 2024 involved receiving (via award) 31,847 shares valued at $0.
Michael Philip Dougherty currently holds 84,203 shares of bioAffinity Technologies, Inc. (BIAF), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Philip Dougherty has been a net neutral trader of BIAF stock. They have purchased $0 and sold $0 worth of shares.
Michael Philip Dougherty's most recent insider trade was on Jan 31, 2024, when they sold 31,847 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.91 |
| Discretionary |